| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 05/03/1992 | CA2054667A1 Cyclopeptides |
| 04/30/1992 | WO1992007000A1 Pharmaceutical composition for the treatment or prevention of a malignant tumor |
| 04/30/1992 | WO1992006711A1 Blood coagulation protein antagonists and uses therefor |
| 04/30/1992 | WO1991018866A3 1,4-diamino-2,3-dihydroxybutanes |
| 04/30/1992 | CA2094372A1 Blood coagulation protein antagonists and uses therefor |
| 04/29/1992 | EP0482966A2 Stabilised derivatives of fragments of hirudin, their preparation and pharmaceutical preparations |
| 04/29/1992 | EP0482605A2 HTLV-II derived peptide |
| 04/29/1992 | EP0482086A1 Antagonists of gm-csf derived from the carboxyl terminus |
| 04/29/1992 | EP0482061A1 Dna coding for a polypeptide signal sequence in vaccinia virus |
| 04/28/1992 | US5109115 Monoclonal antibody specific for bombesin |
| 04/28/1992 | US5108988 Hydrogenated derivatives of antibiotic a/16686 |
| 04/28/1992 | CA1299814C Mitogenic peptides |
| 04/22/1992 | EP0481311A2 Aminoacid derivatives |
| 04/22/1992 | EP0480918A1 Reduced size lhrh analogs |
| 04/22/1992 | CN1060473A Fungicidally active compounds |
| 04/21/1992 | USRE33897 Synthetic polypeptides and antibodies related to Epstein-Barr virus nuclear antigen |
| 04/21/1992 | US5106954 Erythropoietin (epo) peptides |
| 04/19/1992 | CA2053573A1 Amino acid derivatives |
| 04/16/1992 | WO1992005802A1 Polymeric carriers for release of covalently linked agents |
| 04/12/1992 | WO1992006998A1 Cyclopeptides, a method of preparing them, and their use as drugs |
| 04/12/1992 | CA2089747A1 Cyclopeptides, a method of preparing them, and their use as drugs |
| 04/10/1992 | WO1992006992A2 New process for biophosphorylating organic compounds |
| 04/10/1992 | CA2093429A1 Process for biophosphorylating organic compounds |
| 04/08/1992 | EP0479376A1 Peptides immunochemically reactive with antibodies directed against hepatitis Non-A, Non-B virus |
| 04/08/1992 | EP0479086A2 Teicoplanin recovery process |
| 04/08/1992 | EP0478665A1 ANTIGENIC EPITOPES PRESENT ON MEMBRANE-BOUND BUT NOT SECRETED IgA |
| 04/08/1992 | EP0472659A4 T-lymphotropic retrovirus monoclonal antibodies |
| 04/07/1992 | US5102990 Direct radiolabeling of antibodies and other proteins with technetium or rhenium |
| 04/07/1992 | CA1298683C Therapeutic decapeptides |
| 04/06/1992 | CA2052702A1 Peptides immunochemically reactive with antibodies directed against hepatitis non-a, non-b virus |
| 04/03/1992 | WO1992006110A1 Isolated metallopolypeptide: compositions and synthetic methods |
| 04/02/1992 | WO1992006198A1 Salmonella polynucleotide sequence |
| 04/02/1992 | WO1992005271A1 Process for the preparation of c-terminally amidated peptides |
| 04/02/1992 | WO1992005254A1 Novel neurothrophic factor |
| 04/02/1992 | CA2092920A1 Aprotinin analogues |
| 04/02/1992 | CA2091984A1 Salmonella polynucleotide sequence |
| 04/01/1992 | EP0478101A2 Therapeutic use of peptides having thrombospondin-like activity |
| 04/01/1992 | EP0477885A2 Parathyroid hormone derivatives |
| 04/01/1992 | EP0477499A1 Gonadoliberin antagonists |
| 03/31/1992 | US5100875 Novel peptides having plateler aggregation inhibitory activity |
| 03/31/1992 | US5100873 Bombesin antagonist, anticancer agents, oligopeptides |
| 03/31/1992 | CA1298435C Pentapeptides with cell growth regulatory effects and a process for the preparation thereof |
| 03/28/1992 | WO1992006115A1 Antagonists of human gamma interferon |
| 03/28/1992 | CA2092541A1 Antagonists of human gamma interferon |
| 03/27/1992 | CA2052198A1 Therapeutically active peptides and pseudopeptides in the blood clotting cascade, their preparation process and the pharmaceutical compositions containing such |
| 03/26/1992 | WO1992005189A1 Analogues of cyclolinopeptide a and the use thereof |
| 03/26/1992 | CA2090859A1 Analogues of cyclolinopeptide a and the use thereof |
| 03/25/1992 | EP0476933A1 Neurotrophic peptide derivatives |
| 03/25/1992 | EP0476875A2 Process for the purification and concentration of biologically active materials |
| 03/25/1992 | EP0476014A1 Very large scale immobilized polymer synthesis. |
| 03/25/1992 | CN1059729A Polypeptide compound and process for preparation thereof |
| 03/25/1992 | CA2052022A1 Peptides having thrombospondin-like activity and their therapeutic use |
| 03/24/1992 | US5099004 Antibodies such as monoclonal antibodies |
| 03/24/1992 | US5098887 Angiotensin converting enzyme inhibitor |
| 03/24/1992 | US5098828 Immunoassay and testing |
| 03/24/1992 | CA1298035C Antitumor amino acid and peptide derivatives of 1,4- bis¬(aminoalkyl andhydroxyaminoalkyl)amino|-5, 8-dihydroxyanthraquinones |
| 03/19/1992 | WO1992004446A1 Cloning of chicken anaemia dna |
| 03/19/1992 | WO1992004380A1 Specific binding agents |
| 03/19/1992 | WO1992004375A1 Hrsv vaccine |
| 03/19/1992 | WO1992004374A1 Novel polypeptide and anti-hiv drug prepared therefrom |
| 03/19/1992 | WO1992004373A1 Peptide having antiallergic activity |
| 03/19/1992 | WO1992004366A1 Method and apparatus for the rapid synthesis of substrate-bound or free peptides or oligonucleotides, flat material synthesized in this way and the use of such material |
| 03/18/1992 | WO1992005191A1 Fungicidally active compounds |
| 03/18/1992 | EP0475657A2 Pentapeptide and salts thereof having specific inhibiting effect of epidermal cell proliferation |
| 03/18/1992 | EP0475230A1 Methods of conjugating actinomycin D |
| 03/18/1992 | EP0475184A1 Process for the production of peptides by solid phase synthesis |
| 03/18/1992 | EP0474789A1 Cysteine thiol-protected peptides for use in immunoassays |
| 03/18/1992 | EP0474765A1 Diagnostic assay for alzheimer's disease |
| 03/18/1992 | CA2091905A1 Fungicidally active compounds |
| 03/17/1992 | US5097013 Novel peptides possessing a macrophage chemotactic activity |
| 03/13/1992 | CA2051157A1 Neurotrophic peptide derivatives |
| 03/12/1992 | DE4027675A1 Verfahren zur schnellen synthese von grossen zahlen traegergebundener oder freier peptide Method for the rapid synthesis of large numbers traegergebundener or free peptide |
| 03/12/1992 | CA2048094A1 Methods of conjugating actinomycin d |
| 03/11/1992 | EP0474506A1 Antimicrobial peptides |
| 03/11/1992 | EP0474456A2 Oligopeptides exhibiting selective inhibiting effect upon the proliferation of hemopoietic cells |
| 03/11/1992 | EP0474213A1 Method for chromatographic purification of insulins |
| 03/11/1992 | EP0473961A2 Immunoassay reagents and method for determining cyclosporine |
| 03/11/1992 | EP0435877A4 Polynucleotides that encode the human proteoglycan peptide core of the effector cells of the immune response |
| 03/10/1992 | US5095004 Fluorine containing atrial natriuretic peptides |
| 03/10/1992 | US5095003 Cyclic peptides |
| 03/05/1992 | WO1992003474A1 METHOD OF INTERFERING WITH FORMATION OF α-ANTICHYMOTRYPSIN-β-PROTEIN COMPLEX AND SYNTHETIC PEPTIDES FOR USE THEREIN |
| 03/05/1992 | WO1992003147A1 Peptides that block human immunodeficiency virus infections and methods of use thereof |
| 03/04/1992 | EP0473084A2 Polyethylene glycol derivatives, their modified peptides, methods for producing them and use of the modified peptides |
| 03/04/1992 | EP0472662A1 Antifreeze polypeptides |
| 03/04/1992 | EP0472659A1 T-lymphotropic retrovirus monoclonal antibodies |
| 03/04/1992 | EP0472658A1 Fusion proteins having an in vivo post-translational modification site and methods of manufacture and purification |
| 03/03/1992 | US5093531 Polyethylene glycol substituted phenyl glyoxals |
| 03/03/1992 | US5093477 Testing for inhibitors of human immunodeficiency virus |
| 03/03/1992 | US5093320 Immunosuppressants |
| 03/03/1992 | CA1296669C Substance gif-2 and process for production of the same |
| 03/03/1992 | CA1296660C Monoclonal antibody against a ras oncogene p21 related dodecapeptide |
| 03/01/1992 | WO1992004046A1 Novel peptide antigens and immunoassays, test kits and vaccines using the same |
| 03/01/1992 | CA2090470A1 Peptide antigens and immunoassays, test kits and vaccines using the same |
| 03/01/1992 | CA2050063A1 Polyethylene glycol derivatives, their modified peptides, methods for producing them and use of the modified peptides |
| 02/28/1992 | WO1992003473A1 Cd18 peptide medicaments for the treatment of disease |
| 02/28/1992 | CA2090427A1 Cd18 peptide medicaments for the treatment of disease |
| 02/26/1992 | WO1992003458A1 Non-a, non-b hepatitis virus antigen, diagnostic methods and vaccines |
| 02/26/1992 | EP0472220A1 Bradykinin antagonists |
| 02/26/1992 | EP0471752A1 Polypeptides of feline t-cell lymphotropic lentivirus |
| 02/26/1992 | CA2090335A1 Non-a, non-b hepatitis virus antigen, diagnostic methods and vaccines |